Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 3
1972 4
1973 3
1974 3
1975 2
1976 3
1977 5
1978 1
1980 1
1981 1
1982 1
1983 4
1984 4
1985 4
1986 3
1987 2
1988 1
1989 4
1990 3
1991 6
1992 4
1993 5
1994 2
1995 3
1996 6
1997 7
1998 4
1999 6
2000 10
2001 13
2002 19
2003 22
2004 35
2005 43
2006 56
2007 73
2008 78
2009 94
2010 106
2011 143
2012 152
2013 167
2014 184
2015 174
2016 182
2017 184
2018 212
2019 193
2020 241
2021 232
2022 244
2023 209
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

2,807 results

Results by year

Filters applied: . Clear all
Page 1
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.
Bottomly D, Long N, Schultz AR, Kurtz SE, Tognon CE, Johnson K, Abel M, Agarwal A, Avaylon S, Benton E, Blucher A, Borate U, Braun TP, Brown J, Bryant J, Burke R, Carlos A, Chang BH, Cho HJ, Christy S, Coblentz C, Cohen AM, d'Almeida A, Cook R, Danilov A, Dao KT, Degnin M, Dibb J, Eide CA, English I, Hagler S, Harrelson H, Henson R, Ho H, Joshi SK, Junio B, Kaempf A, Kosaka Y, Laderas T, Lawhead M, Lee H, Leonard JT, Lin C, Lind EF, Liu SQ, Lo P, Loriaux MM, Luty S, Maxson JE, Macey T, Martinez J, Minnier J, Monteblanco A, Mori M, Morrow Q, Nelson D, Ramsdill J, Rofelty A, Rogers A, Romine KA, Ryabinin P, Saultz JN, Sampson DA, Savage SL, Schuff R, Searles R, Smith RL, Spurgeon SE, Sweeney T, Swords RT, Thapa A, Thiel-Klare K, Traer E, Wagner J, Wilmot B, Wolf J, Wu G, Yates A, Zhang H, Cogle CR, Collins RH, Deininger MW, Hourigan CS, Jordan CT, Lin TL, Martinez ME, Pallapati RR, Pollyea DA, Pomicter AD, Watts JM, Weir SJ, Druker BJ, McWeeney SK, Tyner JW. Bottomly D, et al. Among authors: cho hj. Cancer Cell. 2022 Aug 8;40(8):850-864.e9. doi: 10.1016/j.ccell.2022.07.002. Epub 2022 Jul 21. Cancer Cell. 2022. PMID: 35868306 Free PMC article.
Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling.
Jeon HM, Kim JY, Cho HJ, Lee WJ, Nguyen D, Kim SS, Oh YT, Kim HJ, Jung CW, Pinero G, Joshi T, Hambardzumyan D, Sakaguchi T, Hubert CG, McIntyre TM, Fine HA, Gladson CL, Wang B, Purow BW, Park JB, Park MJ, Nam DH, Lee J. Jeon HM, et al. Among authors: cho hj. Cancer Cell. 2023 Aug 14;41(8):1480-1497.e9. doi: 10.1016/j.ccell.2023.06.007. Epub 2023 Jul 13. Cancer Cell. 2023. PMID: 37451272 Free article.
Bispecific Antibodies in Multiple Myeloma: Present and Future.
Lancman G, Sastow DL, Cho HJ, Jagannath S, Madduri D, Parekh SS, Richard S, Richter J, Sanchez L, Chari A. Lancman G, et al. Among authors: cho hj. Blood Cancer Discov. 2021 Aug 17;2(5):423-433. doi: 10.1158/2643-3230.BCD-21-0028. eCollection 2021 Sep. Blood Cancer Discov. 2021. PMID: 34661161 Free PMC article. Review.
Targeting MicroRNA-485-3p Blocks Alzheimer's Disease Progression.
Koh HS, Lee S, Lee HJ, Min JW, Iwatsubo T, Teunissen CE, Cho HJ, Ryu JH. Koh HS, et al. Among authors: cho hj. Int J Mol Sci. 2021 Dec 4;22(23):13136. doi: 10.3390/ijms222313136. Int J Mol Sci. 2021. PMID: 34884940 Free PMC article.
Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial.
Nam HS, Kim YD, Heo J, Lee H, Jung JW, Choi JK, Lee IH, Lim IH, Hong SH, Baik M, Kim BM, Kim DJ, Shin NY, Cho BH, Ahn SH, Park H, Sohn SI, Hong JH, Song TJ, Chang Y, Kim GS, Seo KD, Lee K, Chang JY, Seo JH, Lee S, Baek JH, Cho HJ, Shin DH, Kim J, Yoo J, Lee KY, Jung YH, Hwang YH, Kim CK, Kim JG, Lee CJ, Park S, Lee HS, Kwon SU, Bang OY, Anderson CS, Heo JH; OPTIMAL-BP Trial Investigators. Nam HS, et al. Among authors: cho hj. JAMA. 2023 Sep 5;330(9):832-842. doi: 10.1001/jama.2023.14590. JAMA. 2023. PMID: 37668619 Clinical Trial.
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.
Vo JN, Wu YM, Mishler J, Hall S, Mannan R, Wang L, Ning Y, Zhou J, Hopkins AC, Estill JC, Chan WKB, Yesil J, Cao X, Rao A, Tsodikov A, Talpaz M, Cole CE, Ye JC; Multiple Myeloma Research Consortium; Bergsagel PL, Auclair D, Cho HJ, Robinson DR, Chinnaiyan AM. Vo JN, et al. Among authors: cho hj. Nat Commun. 2022 Jun 29;13(1):3750. doi: 10.1038/s41467-022-31430-0. Nat Commun. 2022. PMID: 35768438 Free PMC article.
Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib.
Eun JW, Yoon JH, Ahn HR, Kim S, Kim YB, Lim SB, Park W, Kang TW, Baek GO, Yoon MG, Son JA, Weon JH, Kim SS, Cho HJ, Cheong JY. Eun JW, et al. Among authors: cho hj. Cancer Commun (Lond). 2023 Apr;43(4):455-479. doi: 10.1002/cac2.12414. Epub 2023 Mar 14. Cancer Commun (Lond). 2023. PMID: 36919193 Free PMC article.
2,807 results